1800 202 8726
Getting a second opinion

How Often Does a Second Opinion — Change the Diagnosis?

Second opinion rates are not guesswork — published pathology research has measured them. In a meaningful proportion of cancer cases, a second pathologist reads the same slide differently, and sometimes that difference changes the treatment entirely.

Medically reviewed by Dr. T. Raghavender Reddy, Medical Oncologist, MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · Last reviewed September 2026

  • Measured, not estimated — Published studies in oncology journals have documented the rate of change. It is higher than most patients expect.
  • Two kinds of change — Some changes are minor and do not alter treatment. Others are clinically significant — they change what happens next.
  • Some cancers are riskier — Sarcoma, lymphoma, and melanoma have higher rates of changed diagnoses than many common solid tumours.
  • Seeking one is not disloyalty — Asking for a second opinion is standard practice at major cancer centres worldwide, not a criticism of your first pathologist.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Published oncology studies report that a second pathologist opinion leads to a clinically significant change in roughly one in seven to one in four cancer cases. Rates are higher for sarcoma, lymphoma, and melanoma. A changed diagnosis does not mean error — pathology involves expert judgement, and some cases are genuinely difficult.

What does it mean when a second opinion 'changes' the diagnosis?

Concordant
Both pathologists agree. The original diagnosis stands, and confidence in it increases.
Minor change
A small difference in grade, stage detail, or subtype that does not alter the treatment you receive.
Major (clinically significant) change
A difference that changes the cancer type, the stage, or the recommended treatment. This is the kind of change that matters most to patients and their families.
Discordant
The two opinions disagree substantially. Your oncologist will typically seek a third opinion or molecular testing to resolve it before treatment begins.

What do published studies actually show about the rate of change?

Peer-reviewed studies in journals including JAMA and the Journal of Clinical Oncology consistently report that second opinions on cancer pathology lead to a clinically significant change in a range of roughly one in seven to one in four cases, with variation by cancer type.

Minor changes — differences in grade or subtype that do not alter the treatment plan — occur more frequently than major ones. When researchers separate those from clinically significant changes, the rate is lower but still meaningful.

ASCO acknowledges in published guidance that diagnostic disagreement in cancer pathology is well-documented, and that seeking expert review before starting irreversible treatment is reasonable clinical practice.

Which cancer diagnoses change most often on second opinion?

Sarcoma — a rare family of bone and soft tissue cancers — has among the highest published rates of changed diagnoses. A substantial proportion of sarcoma cases referred to specialist centres receive a different diagnosis or subclassification, which can change the entire treatment approach.

Lymphoma and other blood cancers are complex to classify. Published literature documents well-established rates of diagnostic revision between subtypes that are treated very differently. Melanoma and gastrointestinal cancers with unusual microscopic features also appear consistently in higher-risk categories.

Common solid tumours such as breast and prostate cancer have lower overall rates of major revision. But major changes still occur — and for a decision as consequential as surgery or radiotherapy, even a small rate of meaningful revision justifies the review.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

When is a second opinion most worth seeking?

  • The report uses terms like 'atypical', 'unusual', 'favour', or 'cannot exclude'.
  • Your cancer type is rare or difficult to classify under the microscope.
  • The diagnosis will be used to plan major surgery, radiotherapy, or a long treatment course.
  • Molecular or biomarker testing has not yet been done on the tumour tissue.
  • The clinical picture does not match what your treating team expected.
  • You want confidence before starting a treatment you cannot easily reverse.

Is a second opinion worth the cost and the wait?

The cost of a specialist pathology review in India is indicative and varies by centre, but it is a small fraction of most treatment courses. If the review changes the diagnosis, it may change the treatment entirely — potentially avoiding months of therapy that was not indicated.

Most specialist centres complete a review within one to two weeks of receiving the slides. For most cancers, that window does not affect outcomes. Ask your oncologist whether the wait is clinically safe for your specific stage before arranging it.

A second opinion that confirms the original diagnosis also has value. It reduces uncertainty before a treatment you cannot reverse, and that certainty is part of what you are paying for.

Did you know?

ASCO and ESMO both recognise expert pathology review as a standard clinical step before starting treatment for complex or rare cancers — not as a patient option to be granted on request, but as part of the diagnostic process the clinical team should consider.

The reason is a documented rate of disagreement across published literature that is consistent enough for major cancer centres to build specialist review into their standard intake process.

Source: ASCO and ESMO published guidelines on oncology diagnostic standards

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

HUB — How Accurate Is a Biopsy? Repeats, Errors and Second Opinions

HUB — IHC and Molecular Markers on a Biopsy

HUB — Labs, Slides and Second Opinions on a Biopsy

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

What percentage of pathology second opinions change the diagnosis?

Published oncology literature reports a range rather than a single number, because the rate depends heavily on cancer type and case complexity. Across published series, clinically significant changes occur in roughly one in seven to one in four cases overall. For complex cancers such as sarcoma and lymphoma, the rate is higher. What matters for your situation is the specific cancer type involved — ask your oncologist whether yours falls into a higher-risk category for diagnostic revision.

Does a different second opinion mean the first pathologist made a mistake?

Not necessarily. Pathology involves expert judgement applied to microscopic images, and some cases sit at the border between two diagnoses. Two experienced pathologists can interpret the same slide differently without either being negligent. What matters is resolving the question before treatment starts. If the two opinions disagree substantially, your team will seek molecular testing or a third review to determine which interpretation best fits your full clinical picture.

Which cancers are most likely to get a different result on second opinion?

Sarcoma has the highest published rates of diagnostic change, followed by lymphoma, melanoma, and gastrointestinal cancers with unusual features. Rare tumours and cancers that are difficult to classify under the microscope carry higher rates overall. Common solid tumours such as early breast or prostate cancer have lower rates of major revision, though changes still occur. Your oncologist can tell you where your cancer type sits in the published literature.

How long does a pathology second opinion take in India?

Most specialist centres complete a review within one to two weeks of receiving your slides and the original report. Timing depends on whether slides are sent directly or need to be cut from the tissue block, and on the centre's workload. For most cancer types, a two-week window does not affect outcomes. Ask your oncologist whether the wait is safe for your specific situation and stage before making the arrangement.

Will my oncologist be offended if I ask for a second opinion?

Any oncologist trained at a major centre will not be. Expert pathology review is embedded in guidance from ASCO and ESMO and is standard practice at specialist cancer centres. Some oncologists proactively send complex cases for review without being asked. If you are uncertain how to raise it, a simple framing works: you want certainty before a major treatment decision. That goal is shared by your treating team.

What do I need to send for a second opinion, and who arranges it?

The reviewing pathologist needs your original tissue slides — physical glass slides or new cuts from the paraffin block — together with your original pathology report and relevant clinical history. Digital slide review is available at some centres and avoids transport delay. Your original hospital is required to release your slides; they are your material. Your oncologist can direct you to an appropriate specialist centre for your cancer type, or you can ask CION to coordinate the review.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation